Cambridge, UK: The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is delighted to introduce the new CellBase CT™, a system to automate the ex-vivo expansion of autologous cell therapies on Booth 5 at the Cell & Gene Therapy Forum, in Washington, USA on January 24-26th, 2011.
The new CellBase CT system, which was developed in collaboration with leading cell therapy experts, can be used in a GMP facility for rapid scale up of existing manual cell culture processes in T-flasks. CellBase CT provides researchers with a fully-contained, aseptic cell expansion area where the risk of external contamination or internal cross-contamination has been eliminated. This enables scientists to manufacture multiple autologous cell therapies from many individual patients in parallel, making the CellBase CT a cost-effective alternative to labour intensive manual cell culture.
CellBase CT comes with a range of tools to support validation in a GMP regulated environment, and has been developed and extensively tested to enable clean, reproducible expansion of clinically applicable stem cells and other cell types.
Tim Ward, Director of Cell Culture at TAP explains: “By implementing CellBase CT during Phase II, cell therapy products can be tested alongside manually produced material so that phase III can be fully supported by the automated system. The simple scalability of the system means that the same process technology can be used throughout development and into production, reducing the high level of risk and cost associated with the need to prove equivalency following late stage process changes.”
Ward continues: “We are very excited to be premiering such a major advance at this year’s Cell & Gene Therapy Forum and look forward to meeting progressive scientists that want to discover how the CellBase CT could provide scalable and more affordable manufacturing of their autologous cell therapy products.”
For Further Information Contact:
Matthew Walker, Head of Communications, The Automation Partnership, York Way, Royston, Hertfordshire, SG8 5WY, UK.
Tel: +44 (0) 1763 227200 Fax: +44 (0) 1763-227201
Email: [email protected]
Web: www.automationpartnership.com
Note to Editors
About The Automation Partnership
The Automation Partnership (TAP) provides advanced automation systems and services to improve productivity in life science research, development and production.
For over 20 years TAP has been the leader in the design and development of automated cell culture and processing systems with applications in regenerative medicine, discovery research, bioprocess development and biologics production. Systems include SelecT, CompacT SelecT and Cellmate.
In addition, TAP has a strong track record in providing a range of custom automation solutions for biobanking, biological sample management, compound management and advanced high throughput screening applications.
TAP is a privately-owned company with headquarters near Cambridge, UK and a sales and support facility near Wilmington, Delaware, USA. www.automationpartnership.com